Litcius/Paper detail

Covid-19: Booster doses to be offered to 30 million people in UK

Jacqui Wise

2021BMJ18 citationsDOI

Abstract

Covid-19: Booster doses to be offered to 30 million people in UK Jacqui WiseBooster doses of a covid-19 vaccine are to be offered to the highest risk groups in the UK as a result of new advice from the Joint Committee on Vaccination and Immunisation.A booster dose will be offered to all people who were vaccinated during phase 1 of the vaccine programme, no earlier than six months after they received their second dose.The JCVI advises a preference for the Pfizer-BioNTech vaccine regardless of which vaccine someone had for their primary doses.This follows data from the Cov-boost trial that indicated that this vaccine is well tolerated as a third dose and provides a strong booster response.1

Topics & Concepts

Booster (rocketry)Booster doseCoronavirus disease 2019 (COVID-19)VaccinationMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakFamily medicinePediatricsVirologyImmunologyInternal medicineOutbreakImmunizationInfectious disease (medical specialty)Immune systemDiseaseAstronomyPhysicsSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyHealthcare Systems and Challenges
Covid-19: Booster doses to be offered to 30 million people in UK | Litcius